AstraZeneca and the Royal Academy of Engineering announce new partnership to strengthen support for African health technology entrepreneurs
Earlier today, AstraZeneca (www.AstraZeneca.com) and the Royal Academy of Engineering (The Academy) officially announced a new partnership to build links between African healthcare innovators and A. Network of catalysts of more than 20 global health innovation hubs. The joint venture seeks to stimulate the development of engineering solutions that have the potential to address local challenges with a focus on healthcare technologies.
As part of its commitment to forging international partnerships and solving global challenges, the Academy in 2014 founded the African Prize for Innovation in Engineering (https://bit.ly/3Ah0FC8), an annual award that provides crucial commercialization support to ambitious innovators across sub-Saharan Africa. To date, more than 100 innovators are part of the Africa Prize alumni network. AstraZeneca’s A.Catalyst Network brings together digital, R&D and business resources to reinvent the future of healthcare, working with partners to co-create solutions and establish integrated and strong healthcare systems that benefit people. the whole patient experience. By connecting the Africa Prize entrepreneurs to the A.Catalyst network, as well as to AstraZeneca’s supply chain and a wider ecosystem (including investors), the AstraZeneca-Academy partnership hopes to further strengthen the work of the two organizations. to nurture local talents and strengthen innovation and creativity in the health sector. on the African continent.
As part of this collaboration, AstraZeneca will join the Prize’s network of expert mentors, providing training support to Africa Prize entrepreneurs, giving them access to tailored expertise and experience to help them develop their projects. AstraZeneca will also participate in a webinar series for the Africa Prize alumni network and current cohort, sharing knowledge and insights on health technology and other topics.
Aleksandr Bedenkov, Vice President, Medical International at AstraZeneca, said: “We want to offer entrepreneurs in emerging markets like Africa the same kind of platform and opportunities that their counterparts in other countries would enjoy. The A.Catalyst Network provides healthcare technology entrepreneurs with exciting opportunities to connect and collaborate with a truly global network of expertise and experience, helping to accelerate innovation and ensure more patients can access to the latest healthcare technology solutions.
Barbara Nel, President of the AstraZeneca African Group, said: “This partnership with the Royal Academy of Engineering is an integral part of our unwavering commitment to improve access to healthcare and create lasting impact in Africa. We recognize that advanced science and health care do not happen in isolation; they are the result of collaborations and partnerships to strengthen innovation and creativity in the health sector. We look forward to supporting our Africa Prize entrepreneurs in developing their innovative projects and working together to seek answers to our health challenges for the benefit of all patients in Africa.
Ana Avaliani, Director of Business and Sustainability at the Royal Academy of Engineering, said: “Our partnerships are critical to providing the breadth and depth of support we can offer, which allows the program to accelerate. African entrepreneurial capacity, by producing scalable local solutions. to global challenges. We believe that if an innovator can change a community, a network can transform a continent, and the Africa Prize network truly represents the brightest minds taking on the greatest challenges. We look forward to working with AstraZeneca to amplify the impact of our innovators by harnessing the power of engineering and building a sustainable society and an inclusive economy that works for all.
Going forward, AstraZeneca and the Academy will collaboratively continue to explore other partnership opportunities to support the health system in the region and beyond.
Distributed by APO Group on behalf of AstraZeneca.
For media inquiries, please contact:
The Royal Academy of Engineering
AstraZeneca (LSE/STO/ Nasdaq: AZN) is a global science-based biopharmaceutical company focused on the discovery, development and commercialization of prescription drugs in oncology, rare diseases and biopharmaceuticals, including cardiovascular, renal and metabolism, and respiratory and immunology. Headquartered in Cambridge, UK, AstraZeneca operates in more than 100 countries and its innovative medicines are used by millions of patients around the world. Please visit AstraZeneca.com and follow the company on Twitter @AstraZeneca.
About the A.Catalyst Network:
A.Catalyst Network is an interconnected global network of more than 20 AstraZeneca healthcare innovation hubs, comprised of physical locations and virtual partnerships. The network embodies our commitment to growth through innovation (https://bit.ly/3lgCQ9s) and is a key part of our patient-centric workflow, as a ‘catalyst’ for the development of new solutions. to support patients. It aims to address healthcare challenges, increase access to healthcare, and scale and showcase patient-facilitated innovation around the world.
About the Royal Academy of Engineering:
The Royal Academy of Engineering harnesses the power of engineering to build a sustainable society and an inclusive economy that works for everyone. Together with our fellows and partners, we develop talents and skills for the future, foster innovation and build global partnerships, and influence policy and engage the public. Together, we are working to meet the greatest challenges of our time.
About the Africa Prize for Engineering Innovation:
The African Prize for Engineering Innovation, founded by the Royal Academy of Engineering, is Africa’s largest award dedicated to engineering innovation. It provides crucial support to ambitious African innovators developing scalable engineering solutions to local challenges, demonstrating the importance of engineering as a catalyst for better quality of life and economic development. The program is designed to help engineers achieve commercial success with their innovations. After an eight-month training and mentoring period, the Africa Prize for Engineering Innovation is awarded to a chosen winner, who receives £ 25,000, while three finalists receive £ 10,000 each.
Africanews provides APO Group content as a service to its readers, but does not edit the articles it publishes.